DrugPatentWatch Database Preview
LITHOTABS Drug Profile
Which patents cover Lithotabs, and when can generic versions of Lithotabs launch?
The generic ingredient in LITHOTABS is lithium carbonate. There are fifteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
Summary for LITHOTABS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 58 |
| Patent Applications: | 101 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | LITHOTABS at DailyMed |
Medical Subject Heading (MeSH) Categories for LITHOTABS
Synonyms for LITHOTABS
| 10377-37-4 (mono-lithium salt) |
| 12767-19-0 |
| 1312765-65-3 |
| 216964-61-3 |
| 2BMD2GNA4V |
| 554-13-2 |
| AC1L1WO8 |
| AC1LANIP |
| AC1Q1U57 |
| ACMC-209lmw |
| AKOS015904647 |
| AN-45875 |
| ANGC-554-13-2 |
| ANW-32310 |
| B7705 |
| C07964 |
| Camcolit |
| Candamide |
| Carbolite |
| Carbolith |
| Carbolithium |
| Carbolithium IFI |
| Carbolitium |
| Carbonic Acid Dilithium Salt |
| Carbonic acid lithium salt |
| Carbonic acid lithium salt (Li2CO3) |
| Carbonic acid, dilithium salt |
| Carbonic acid, lithium salt |
| Carbonic acid, lithium salt (1:2) |
| CCRIS 3153 |
| Ceglution |
| CHEBI:6504 |
| CHEMBL1200826 |
| Cibalith-e |
| CLi2O3 |
| CP 15467-61 |
| CP-15,467-61 |
| CP-15467-61 |
| CP-1546761 |
| CTK1G9703 |
| D00801 |
| D04UUH |
| Dilithium carbonate |
| Dilithium Carbonate, Dilithium Salt, Carbonic Acid |
| dilithium trioxidocarbonate |
| dilithium(1+) ion carbonate |
| diLithoTab CO3 |
| Dilthium Carbonate |
| DTXSID1023784 |
| Duralite |
| EC 209-062-5 |
| EINECS 209-062-5 |
| Eskalite |
| Eskalith |
| Eskalith (TN) |
| Eskalith CR |
| Eutimin |
| FT-0627895 |
| GK3300 |
| HSDB 3351 |
| Hypnorex |
| I14-16784 |
| I494 |
| IN000219 |
| IN006073 |
| KS-0000025D |
| KSC269O0H |
| L0224 |
| Li2CO3 |
| Limas |
| Liskonum |
| Litard |
| Lithane |
| Lithea |
| Lithicarb |
| Lithinate |
| Lithionate |
| LITHIUM CARBONATE |
| Lithium carbonate (2:1) |
| Lithium carbonate (JP17/USP) |
| Lithium carbonate (Li2CO3) |
| Lithium carbonate [USAN:JAN] |
| Lithium carbonate [USAN:USP:JAN] |
| Lithium carbonate, 99% 500g |
| LITHIUM CARBONATE, ACS |
| Lithium carbonicum |
| Lithium Phasal |
| Lithium QD |
| Lithium, Reference Standard Solution |
| Lithiumcarbonat |
| Lithiumcarbonate |
| Lithizine |
| Litho-Carb |
| Lithobid |
| Lithobid (TN) |
| Lithobie |
| Lithonate |
| Lithotabs Priadee |
| Liticar |
| LS-88061 |
| LTBB002486 |
| Manialith |
| Maniprex |
| MFCD00011084 |
| Micalith |
| MolPort-003-927-648 |
| Neurolepsin |
| NSC-16895 |
| OR284070 |
| Pfi-lithium |
| Pfl-Lithium |
| Phasal |
| Plenur |
| Priadel |
| Quilonorm |
| Quilonum retard |
| RL04084 |
| RTR-019539 |
| Teralithe |
| Teralithe [French] |
| TR-019539 |
| TRA0065195 |
| UNII-2BMD2GNA4V |
| XGZVUEUWXADBQD-UHFFFAOYSA-L |
| Zabuyelite |
US Patents and Regulatory Information for LITHOTABS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | LITHOTABS | lithium carbonate | TABLET;ORAL | 016980-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
